DRW Securities’s Oruka Therapeutics ORKA Stock Holding History

DRW Securities’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-66	Closed	-$168K	–	257
2013 Q4	$168K	Buy	+66	New	+$152K	0.01%	192

Other funds holding ORKA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RCM

Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return

Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

DRW Securities's ORKA Position: Q1 2014 in Review

DRW Securities sold out of Oruka Therapeutics (ORKA) in Q1 2014, closing a stake of 66 shares — an estimated $168K sold.

DRW Securities first reported a position in ORKA in Q4 2013 and held it in 1 quarter. The position peaked at $168K in Q4 2013. 11 funds tracked by Wall St. Rank hold ORKA as of Q1 2014.

DRW Securities reported no remaining Oruka Therapeutics position as of Q1 2014 after selling out during the quarter.
DRW Securities sold 66 Oruka Therapeutics shares in Q1 2014, an estimated $168K.
DRW Securities first reported a position in Oruka Therapeutics in Q4 2013 and held it in 1 quarter.
DRW Securities's Oruka Therapeutics position peaked at $168K in Q4 2013.
11 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2014.

Based on DRW Securities's 13F filing for Q1 2014, filed 16 May 2014.